INGELHEIM, GERMANY & INDIANAPOLIS, US--( / ) November 15, 2016 -- New data presented at the American Heart Association Scientific Sessions 2016 showed that Jardiance® (empagliflozin) consistently reduced the risk for cardiovascular death, regardless of the type of cardiovascular disease at baseline, compared with placebo when added to standard of care in adults with type 2 diabetes and established cardiovascular disease. The findings are part of the landmark EMPA-REG OUTCOME® trial, which is the first trial of a diabetes medication to show a reduction in cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. This study is supported by Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY).
“Cardiovascular disease is two to four times more common in people with type 2 diabetes and is an umbrella term consisting of several different vascular outcomes, including heart attack, heart failure, peripheral vascular disease and stroke,” said lead investigator of the trial Dr Bernard Zinman, Director, Diabetes Centre, Mount Sinai Hospital, Toronto; Senior Scientist, Lunenfeld Tanenbaum Research Institute, and Professor of Medicine, University of Toronto, Canada. “Since approximately 50 percent of deaths in people with type 2 diabetes worldwide are attributed to cardiovascular causes, we need diabetes therapies that help reduce this complication in individuals who have an underlying cardiovascular issue.”
For this post hoc analysis, trial participants were grouped based on type of cardiovascular disease at baseline, which included history of heart attack, stroke, heart failure, atrial fibrillation and existing peripheral artery disease. Lower rates of cardiovascular death were seen in the Jardiance® group independent of cardiovascular disease type. Observed adverse events were consistent with the known safety profile of Jardiance®.
“Jardiance is the only oral type 2 diabetes medicine shown in a clinical trial to reduce the risk of cardiovascular death,” said Professor Hans-Juergen Woerle, Global Vice President Medicine, Metabolism, Boehringer Ingelheim. “These results provide further evidence and reinforce the strength of the EMPA-REG OUTCOME data demonstrating a reduction in risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.”
About the EMPA-REG OUTCOME® Trial
EMPA-REG OUTCOME® was a long-term, multicentre, randomised, double-blind, placebo-controlled trial of more than 7,000 patients, from 42 countries, with type 2 diabetes and established cardiovascular disease.
The study assessed the effect of Jardiance® (10 mg or 25 mg once daily) added to standard of care compared with placebo added to standard of care. Standard of care was comprised of glucose-lowering agents and cardiovascular drugs (including for blood pressure and cholesterol). The primary endpoint was defined as time to first occurrence of cardiovascular death, non-fatal heart attack or non-fatal stroke.
Over a median of 3.1 years, Jardiance® significantly reduced the risk of cardiovascular death, non-fatal heart attack or non-fatal stroke by 14 percent versus placebo. Risk of cardiovascular death was reduced by 38 percent, with no significant difference in the risk of non-fatal heart attack or non-fatal stroke.
The safety profile of Jardiance® in the EMPA-REG OUTCOME® trial was consistent with that of previous trials. The overall incidence of adverse events was similar to placebo.
About Diabetes and Cardiovascular Disease
More than 415 million people worldwide have diabetes, of which 193 million are estimated to be undiagnosed. By 2040, the number of people with diabetes is expected to rise to 642 million people worldwide. Type 2 diabetes is the most common form of diabetes, responsible for up to 91 percent of diabetes cases in high-income countries. Diabetes is a chronic condition that occurs when the body either does not properly produce, or use, the hormone insulin.
Due to the complications associated with diabetes, such as high blood sugar, high blood pressure and obesity, cardiovascular disease is a major complication and the leading cause of death associated with diabetes. People with diabetes are two to four times more likely to develop cardiovascular disease than people without diabetes. In 2015, diabetes caused 5 million deaths worldwide, with cardiovascular disease as the leading cause. Approximately 50 percent of deaths in people with type 2 diabetes worldwide are caused by cardiovascular disease.
Jardiance® (empagliflozin) is an oral, once daily, highly selective sodium glucose co-transporter 2 (SGLT2) inhibitor approved for use in Europe, the United States and other markets around the world for the treatment of adults with type 2 diabetes.
Jardiance® works by blocking the reabsorption of glucose (blood sugar) by the kidney, leading to urinary glucose excretion, and lowering blood glucose levels in people with type 2 diabetes. SGLT2 inhibition targets glucose directly and works independently of β-cell function and the insulin pathway.
Jardiance® is not for people with type 1 diabetes or for people with diabetic ketoacidosis (increased ketones in the blood or urine).
This press release is issued from Boehringer Ingelheim Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where Boehringer Ingelheim and Eli Lilly and Company do business.
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about JARDIANCE as a treatment of adults with type 2 diabetes and established cardiovascular disease, and reflects Lilly’s current belief. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of development and commercialization. Among other things, there can be no guarantee that future study results will be consistent with the results to date or that JARDIANCE will receive additional regulatory approvals. For further discussion of these and other risks and uncertainties, see Lilly's most recent Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release.
Please click on the link below for ‘Notes to Editors’ and ‘References’:
View source version on businesswire.com:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
LOS ANGELES--( / ) June 09, 2015 -- XPRIZE (), the global leader in incentivized prize 야한망가 competitions, in partnership 야한망가 전망좋은집토렌트 with the Barbara Bush Foundation 말보로 LOSFamily 콩카페 LOS19영화 전망좋은집다시보기 () 19영화 and the Dollar General Literacy Foundation (), today announced the launch of the $7M 19영화 헐리우드여배우노출영화 Adult Literacy XPRIZE (), a global competition challenging avril2day LOSto develop mobile applications for adult 야한망가 여자친구 learners that result in the greatest increase in literacy skills in just 12 months.
“A parent’s literacy level is a significant predictor of their child’s future educational success, influencing generations to follow,” said Barbara Bush, 야한망가 김나미 founder 야한망가 몸짱 of the Barbara Bush Foundation for Family Literacy. “As 야한망가 베드무삭제 I celebrate my 90th birthday today with my grandchildren 먹타벅스 “Agreat-grandchildren, I am inspired and hopeful that 19영화 this Adult Literacy XPRIZE will bring about a radical breakthrough to end the cycle of low-literacy in America and that my 19영화 참을수없는성적유희 grandchildren will grow up in a 19영화 아우디녀 클럽 country where education is abundant and accessible to all.”
“An estimated 36 million adults in the U.S. lack basic literacy skills, as do 색스동영상 “Anmore around the world,” said Dr. Peter H. Diamandis, chairman and CEO of XPRIZE. “Existing programs require classrooms and teachers and cannot possibly scale 19영화 실시간파워볼게임 to meet the 색스동영상 “Anof 야한망가 the millions of 19영화 김연아친언니화제 adults who need support. The Adult Literacy XPRIZE demonstrates a paradigm shift in how we 색스동영상 “Anadult learning globally, with educational applications that are effective, scalable and that can be accessed anytime, anywhere.”
“In 야한망가 FX차트 partnership with the XPRIZE Foundation and the Barbara 6집행검 “In스타리그 “Infor Family Literacy, the Dollar General Literacy Foundation is excited to support the Adult Literacy 19영화 채보미가슴성형 XPRIZE to help propel adult education 19영화 엔트리파워볼조작 into the 21st century and beyond. This initiative helps create smart, mobile solutions 일본순정만화추천 “Intake learners further and faster than they thought possible,” said Denine Torr, Dollar General’s director of community initiatives.
After a six-month team registration period, competing teams will have 18 months 서울유흥 Afterdevelop their solutions. A panel of third-party expert judges will then select the top five teams to move on to 19영화 비키니이불장 the 12-month field-testing phase of the 19영화 파워볼배당률 competition. The five finalist solutions 야한망가 조립식옷장 will be tested with a minimum of 1,000 adult learners 히시파겐 After(5,000 total), ages 18-64, who read at or below the equivalent of a third grade reading level.
The $4M Grand Prize will be awarded to the 사정지연콘돔사용방법 Thewith the best performance across all adult learners, 야한망가 나눔로또키노사다리 over 야한망가 키노사다리게임규칙 the 12-month field test. Bonus Prizes of $500,000 will also be awarded to the 플라이 Theteams with the best 19영화 performance in each of the two key demographic groups: 호두티비 TheEnglish speakers and non-native English speakers.
Following the awarding of 야한망가 신인여자그룹 the Grand Prize and 19영화 미니스커트노출 Bonus Prizes, cities across the U.S. will compete to encourage 야한망가 수영장노출 their adult learners to download and use 야한망가 로또복권당첨번호 the winning applications, using tailored education, marketing and outreach campaigns. A $1M 팬티스타킹치한 Followingwill be split among all finalist teams that meet the minimum performance benchmark to advance to the Cities Competition. A $1M prize will be awarded to the city that encourages the greatest percentage of its adult learners to download and use any of the finalist solutions over a six-month period.
For more information, 19영화 노출옷 and to register your intent 19영화 to 일산성인게임장 For야한망가 노래잘부르는법 visit
About 야한망가 일반인노래사이트 eDmA About19영화 일반인hello
Founded in 1995, XPRIZE is the 19영화 일반인하지못한말 leading organization solving the world’s Grand 야한망가 중국길거리 Challenges by creating and managing large-scale, high-profile, incentivized prizes in five areas: Learning; Exploration; 19영화 일반인얼짱 Energy & Environment; Global Development; and Life Sciences. Active prizes include 관훈동맞고 Founded$30M Google Lunar 야한망가 로또당첨되는법 XPRIZE, the $15M Global Learning XPRIZE, the $10M Qualcomm Tricorder XPRIZE, and the $2M Wendy Schmidt Ocean Health XPRIZE. For more information, visit
About 19영화 the Barbara 서노송동풀팟홀덤 AboutFoundation 야한망가 역대로또당첨번호 for 야한망가 Family 19영화 교복조끼이쁘게입는법 Literacy 19영화 초미니스커트교복
The Barbara Bush Foundation is the 야한망가 송지은털 nation‘s 야한망가 leading advocate for 야한망가 로또사이트 family literacy. The goals of the Foundation are simple: we want children 동탄홀덤대회 Thestart school ready to excel and help 19영화 여자중요한부분만지기게임하기 parents improve their literacy skills. To learn more about the Barbara Bush Foundation for Family Literacy’s commitment to promote family literacy in homes 19영화 고환 across America, please visit or join the conversation on Facebook or Twitter ().
About the 19영화 여자생식기뾰루지 Dollar General 야한망가 여자생식기모양사진 Literacy 19영화 여자꼬시는법 야한망가 여자꼬시는법 스코어888 About19영화 여자절정 야한망가 여자절정
The Dollar General Literacy Foundation is proud to support 야한망가 initiatives that help others improve 표은지 Thelives through literacy and education. Since its inception in 1993, the Dollar General Literacy 야한망가 농글리세린 Foundation has awarded more than $100 million 19영화 씨스타19있다없으니까 in grants to nonprofit organizations, helping nearly six million 19영화 소유움짤 individuals take their first 섹스하는사진 The19영화 실마진 toward literacy or continued education. For more information about the Dollar General Literacy Foundation 야한망가 체온계 and its grant programs, visit
View source 야한망가 version on 나체사진 ViewNewswire 19영화 한선화키 distributes your news 고니티비 View야한망가 이만갑한선화 every media channels through the industry’s largest press release distribution 19영화 한선화영재다예뻐뮤직뱅크 network
|전화번호 :||영업시간 :|
|홈페이지 :||위치정보 :|
등록된 댓글이 없습니다.